These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18062156)

  • 1. [Unexpected loss of therapeutic effect of oxcarbazepine].
    Lampert ML; Rätz Bravo AE; Brugger S; Haschke M
    Praxis (Bern 1994); 2007 Nov; 96(47):1843-8. PubMed ID: 18062156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):472-6. PubMed ID: 2738589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
    Mogensen PH; Jórgensen L; Boas J; Dam M; Vesterager A; Flesch G; Jensen PK
    Acta Neurol Scand; 1992 Jan; 85(1):14-7. PubMed ID: 1546529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Pain; 2002 Feb; 95(3):259-266. PubMed ID: 11839425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
    Poletti-Jabbour J; Wiegering-Rospigliosi A; Pereyra-Elías R; Elías-Barrera CC
    Eur J Clin Pharmacol; 2016 Aug; 72(8):1031-2. PubMed ID: 27130345
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxcarbazepine in neuropathic pain.
    Nasreddine W; Beydoun A
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1615-25. PubMed ID: 17922625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
    Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
    J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependent enzyme induction by oxcarbazepine?
    Patsalos PN; Zakrzewska JM; Elyas AA
    Eur J Clin Pharmacol; 1990; 39(2):187-8. PubMed ID: 2253672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on pharmacotherapy for trigeminal neuralgia.
    Pergolizzi JV; LeQuang JA; El-Tallawy SN; Wagner M; Ahmed RS; Varrassi G
    Expert Rev Neurother; 2024 Aug; 24(8):773-786. PubMed ID: 38870050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs used in the management of trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):439-50. PubMed ID: 1408017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).
    Besi E; Boniface DR; Cregg R; Zakrzewska JM
    J Headache Pain; 2015; 16():563. PubMed ID: 26335440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trigeminal neuralgia: drug therapy : The new German guideline].
    Ruscheweyh R; Gierthmühlen J; Hedderich DM; Goßrau G; Leis S
    Schmerz; 2024 Aug; 38(4):283-292. PubMed ID: 38689064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of trigeminal neuralgia.
    Sindrup SH; Jensen TS
    Clin J Pain; 2002; 18(1):22-7. PubMed ID: 11803299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Management of Trigeminal Neuralgia in the Elderly.
    Oomens MA; Forouzanfar T
    Drugs Aging; 2015 Sep; 32(9):717-26. PubMed ID: 26336972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world effectiveness and tolerability of carbamazepine and oxcarbazepine in 354 patients with trigeminal neuralgia.
    Di Stefano G; De Stefano G; Leone C; Di Lionardo A; Di Pietro G; Sgro E; Mollica C; Cruccu G; Truini A
    Eur J Pain; 2021 May; 25(5):1064-1071. PubMed ID: 33428801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity.
    Zakrzewska JM; Ivanyi L
    J Allergy Clin Immunol; 1988 Jul; 82(1):110-5. PubMed ID: 3392362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interactive metabolism effect of oxcarbazepine coadministered with tricyclic antidepressant therapy for OCD symptoms.
    Baird P
    J Clin Psychopharmacol; 2003 Aug; 23(4):419-20. PubMed ID: 12920423
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic drug monitoring of oxcarbazepine].
    Bouquié R; Dailly E; Bentué-Ferrer D;
    Therapie; 2010; 65(1):61-5. PubMed ID: 20205998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of trigeminal neuralgia with spasmolytics].
    Savitskaia ON
    Sov Med; 1974 Sep; 0(9):21-5. PubMed ID: 4411359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.